Peter Mac Testing Validates AlgoraeOS - v2 Launched

• Independent preclinical validation of AlgoraeOS v1 (“AOS1”) completed at the Victorian Centre for Functional Genomics at the Peter MacCallum Cancer Centre, led by Professor Kaylene Simpson and Chief Scientific Officer, Dr James McKenna. • 21 drugs predicted by AOS1 were tested in combination with CBD across four cancer cell models, generating approximately 10,000 data points. • The program cover